Question · asked by 1 review
Withdrawal of anticholinergic medication vs continuing anticholinergic medication: Social confidence, social inclusion, social networks, or personalised quality of life
- Population
- chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
- Intervention
- Withdrawal of anticholinergic medication
- Comparison
- continuing anticholinergic medication
- Outcome
- Social confidence, social inclusion, social networks, or personalised quality of life
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Withdrawal of anticholinergic medication vs continuing anticholinergic medication Social confidence, social inclusion, social networks, or personalised quality of life · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia Anticholinergic medication for antipsychotic‐induced tardive dyskinesia (2018) · Cochrane Headline outcomes only | no estimate extracted | 0 studies · 0 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.